Quadrature Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Quadrature Capital's EW Position: Q4 2024 in Review
Quadrature Capital sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 163,220 shares — an estimated $10.8M sold.
Quadrature Capital first reported a position in EW in Q2 2015 and held it in 14 quarters. The position peaked at $21.4M in Q4 2019. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.
- Quadrature Capital reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
- Quadrature Capital sold 163,220 Edwards Lifesciences shares in Q4 2024, an estimated $10.8M.
- Quadrature Capital first reported a position in Edwards Lifesciences in Q2 2015 and held it in 14 quarters.
- Quadrature Capital's Edwards Lifesciences position peaked at $21.4M in Q4 2019.
- 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.
Based on Quadrature Capital's 13F filing for Q4 2024, filed 13 Feb 2025.